Contact
Us
Resources
Congressional Scorecards
Home Statement of Purpose
Current
Action Alert ( sign up to receive AFA of
PA Action Alerts Education
Issues
Homosexual Agenda
Pornography
Fight
Pro-Life Issues
Archives
![](images/btn_donate_LG.gif)
|
|
Thursday
September 20, 2007
Deaths Associated with HPV
Vaccine Start Rolling In, Over 3500 Adverse Affects Reported
By John-Henry Westen
TORONTO, September 20, 2007 (LifeSiteNews.com) - As Canada, in large part
due to aggressive behind the scenes lobbying, rolls out the
not-comprehensively-tested Merck HPV vaccine for girls as young as nine, a
look at developments on the vaccine south of the border should cause
Canadians serious concern. In the United States a similar lobby campaign
by the same company launched the mass HPV vaccination of girls beginning
in June last year.
In just little over a year, the HPV vaccine has been associated with at
least five deaths, not to mention thousands of reports of adverse effects,
hundreds deemed serious, and many that required hospitalization.
Judicial Watch, a U.S. government watchdog, became concerned while noting
large donations to key politicians originating from Merck. A freedom of
information request from the group in May of this year discovered that
during the period from June 8, 2006 - when the vaccines received approval
from the U.S. Food and Drug Administration (FDA) - to May 2007 there were
1,637 reports of adverse reactions to the HPV vaccine reported to the FDA.
Three deaths were related to the vaccine, including one of a 12-year-old.
One physician's assistant reported that a female patient "died of a blood
clot three hours after getting the Gardasil vaccine." Two other reports,
on girls 12 and 19, reported deaths relating to heart problems and/or
blood clotting.
As of May 11, 2007, the 1,637 adverse vaccination reactions reported to
the FDA via the Vaccine Adverse Event Reporting System (VAERS) included
371 serious reactions. Of the 42 women who received the vaccine while
pregnant, 18 experienced side effects ranging from spontaneous abortion to
fetal abnormities.
Side effects published by Merck & Co. warn the public about potential
pain, fever, nausea, dizziness and itching after receiving the vaccine.
Indeed, 77% of the adverse reactions reported are typical side effects to
vaccinations. But other more serious side effects reported include
paralysis, Bells Palsy, Guillain-Barre Syndrome, and seizures.
Judicial Watch informed LifeSiteNews.com that a subsequent request for
information on adverse reactions to the HPV vaccine, covering the period
from May 2007 to September 2007, found that an additional 1800 adverse
reactions have been reported, including more deaths. Exactly how many
more deaths occurred will be released in the coming days, Judicial Watch's
Dee Grothe informed LifeSiteNews.com.
The LifeSiteNews.com report on the moneyed lobbying efforts of Merck in
the U.S. was reported in February. (see http://www.lifesite.net/ldn/2007/feb/07020204.html
)
However the Canadian lobby effort by Merck's Canadian affiliate Merck
Frosst Canada has been underway using powerful lobbyists with close
connections to the politicians who have signed off on massive government
funded vaccination programs.
The Toronto Star recently reported that Merck Frosst Canada Ltd hired
public relations giant Hill & Knowlton to push the immunization strategies
using some well-connected lobbyists: Ken Boessenkool, a former senior
policy adviser to Prime Minister Stephen Harper; Bob Lopinski, formerly
with Premier Dalton McGuinty's office; and Jason Grier, former chief of
staff to Health Minister George Smitherman.
Harper's Conservative Government approved Merck's HPV vaccine Gardasil in
July and later announced a $300 million program to give the vaccine to
girls from ages 9-13. That of course is only the beginning of what Merck
likely hopes will be a much larger vaccination of all potentially sexually
active women in Canada who are not already HPV infected. In August,
McGuinty's Ontario Liberals, on the advice of his Health Minister George
Smitherman, announced that all Grade 8 girls will have free access to
Gardasil.
One of the major complaints by physicians is that the HPV vaccination
program has been implemented before adequate testing has been completed.
Long-term effects of the vaccine remain unknown. Many are asking why the
seemingly reckless rush?
At least one answer to that question comes from the fact that Merck
currently is the sole provider of an HPV vaccine with its Gardasil
product. A competing HPV vaccine, Glaxo Smith Kline's Cervarix, is set to
hit the market in January 2008. As more children are vaccinated with
Gardasil, fewer will be able to later receive the necessary repeat
boosters of a competing, incompatible vaccine. Merck is in a race to
capture as much of the market as it can, consuming many millions of
taxpayer dollars.
U.S. sales of Gardasil are expected to reach $1 billion in the first year
of its availability.
Read Previous
LifeSiteNews.com coverage:
The reports from the FDA
Vaccine Adverse Event Reporting System detailing the three previous deaths
are available here:
http://www.lifesitenews.com/ldn/2007_docs/GardasilVAERSDeaths.pdf
The reports detailing all 1637 adverse effects are here:
http://www.lifesitenews.com/ldn/2007_docs/GardasilVAERSReports.pdf
URL:
http://www.lifesitenews.com/ldn/2007/sep/07092004.html
Copyright 2002-2009 American Family
Association of PA |